PTAB challenges

Proceedings Overview

A diligent search for AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method Review) specifically targeting U.S. Patent No. 10,134,054 has revealed no active or concluded PTAB proceedings on file with the USPTO Open Data Portal or in publicly accessible databases as of today's date. The information provided in the prompt's "PTAB proceedings on file" section stating "The USPTO ODP API returns no AIA trial proceedings for this patent as of the most recent ingest" is consistent with web search results.

While Almondnet, Inc. has engaged in significant district court litigation involving this patent and related patents, with some settlements indicating "numerous Inter Partes Review ('IPR') patent-office wins" for Almondnet across its portfolio, no specific IPR, PGR, or CBM proceeding number or details could be found for US10134054. The listed district court cases for US10134054 against Roku, Samsung, LG, Vizio, Microsoft, and Amazon all concluded with settlements or dismissals with prejudice, often before the patent's validity could be fully litigated through PTAB or district court trials. For example, the jury verdict against Amazon concerned US Patent Nos. 8,671,139 and 7,822,639, not US10134054.

One search result mentioned an IPR (IPR2022-01319) filed by Microsoft against AlmondNet, Inc. and linked it to a district court case (6:21-cv-00897) where US10134054 was asserted. However, publicly available information for IPR2022-01319 does not list US10134054 as the challenged patent. It appears this IPR may have targeted other patents in Almondnet's portfolio that were also involved in the broader litigation against Microsoft.

Therefore, the bottom-line defensive posture for a defendant is that US10134054 has no known PTAB activity on file, meaning its claims have not been challenged or confirmed by the Patent Trial and Appeal Board.

Strategic Summary

As of the current date, no claims of US10134054 are known to be CANCELED or SUSTAINED by the PTAB. All claims (1-15) remain UNTESTED by inter partes review or other AIA trial proceedings. This means there is no estoppel landscape under 35 U.S.C. § 315(e)(2) for this particular patent, leaving all prior-art grounds potentially available for a future challenger.

The absence of PTAB activity is noteworthy, especially given the patent's involvement in multiple district court infringement lawsuits which primarily resulted in settlements. This could indicate that defendants in those cases found settlement to be a more viable strategy than pursuing IPRs against this specific patent, or that their litigation strategies focused on other patents in Almondnet's portfolio. The general statement about Almondnet having "numerous Inter Partes Review ('IPR') patent-office wins" refers to its broader IP portfolio, not specifically US10134054.

Recommended Next Steps

If you are a defendant facing assertion of US10134054, the absence of PTAB activity means that the patent's validity has not been directly challenged and adjudicated at the PTAB. This presents both an opportunity and a risk:

• Opportunity: All prior art arguments remain available to challenge the patent's validity if a new PTAB proceeding (e.g., IPR) were to be initiated. There is no pre-existing PTAB decision upholding the claims against specific prior art, which could make an IPR a viable defensive strategy.
• Risk: Without a PTAB record, there is no judicial or administrative precedent specifically validating or invalidating the claims of US10134054. The patent owner's "wins" in the cited district court cases were settlements, not findings of validity after full litigation.

Given the patent's projected expiration date of June 14, 2027, the window for initiating an IPR is closing if an IPR is filed within one year of a complaint alleging infringement of the patent. Consult with patent litigation counsel to assess the strength of potential invalidity arguments against the claims of US10134054 in light of prior art and to determine the feasibility and strategic value of filing an IPR at this stage.